Active Ingredients
(in each extended-release tablet)
Guaifenesin USP, 600 mg
Dextromethorphan Hydrobromide USP, 30 mg
Guaifenesin USP, 1200 mg
Dextromethorphan Hydrobromide USP, 60 mg
The following Structured Product Label (SPL) was submitted to the FDA by Dr. Reddy's Laboratories Inc. for the product Guaifenesin And Dextromethorphan Hbr (NDC 43598-115). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purposes, uses, warnings, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Guaifenesin USP, 600 mg
Dextromethorphan Hydrobromide USP, 30 mg
Guaifenesin USP, 1200 mg
Dextromethorphan Hydrobromide USP, 60 mg
Expectorant
Cough suppressant
These could be signs of a serious illness.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
For 600 mg/30 mg:
For 1200 mg/60 mg:
carbomer homopolymer type B, colloidal silicon dioxide, FD & C Blue #1, ferric oxide yellow, hypromellose, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
call 1-888-375-3784 Weekdays (9am - 8pm EST)
You may also report side effects to this phone number.
* Please review the disclaimer below.